Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G SAQsReproductive endocrinology and infertility

O&G SAQs · Reproductive endocrinology and infertility

Assisted reproductive technology — structured SAQ (15 marks)

FRANZCOG-format structured SAQ on assisted reproduction: infertility and ART definitions and ICSI indication, the staged IVF/ICSI pathway, protocol and embryo-transfer decisions with OHSS prevention, and age-stratified cumulative live-birth counselling. Per-sub-part marking rubric included.

15 marks20 min3 min readVerification in progress

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
A 38-year-old woman and her 40-year-old partner present after two years of involuntary infertility. She has regular cycles, patent tubes, a normal day-3 hormone profile and an AMH in the normal range; his semen analysis shows severe oligoasthenoteratozoospermia. They are counselled toward IVF and ask about their realistic chance and the plan. (a) Define infertility and assisted reproductive technology, and state why ICSI (rather than conventional IVF) is indicated here. (3 marks) (b) Outline the staged IVF/ICSI pathway, naming each step. (4 marks) (c) Discuss the protocol and embryo-transfer decisions you would make and justify each, including prevention of ovarian hyperstimulation syndrome. (5 marks) (d) Counsel the couple on their realistic chance of a live birth, citing cumulative live-birth data, and name the principal complications of ART. (3 marks)

How this SAQ is marked

Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: precise definitions, the named steps of the pathway, the justified protocol and embryo-transfer decisions, and the age-stratified cumulative live-birth figures. Write in short labelled points, not prose paragraphs. Answer the sub-part you are asked. [1]

Reveal model answer and mark schemeShowHide

(a) Definitions and ICSI indication (3 marks)

  • Infertility is a disease of the male or female reproductive system, clinically the failure to achieve a pregnancy after 12 months or more of regular unprotected intercourse (International Glossary, 2017).[1]
  • Assisted reproductive technology (ART) is any intervention involving the in vitro handling of human oocytes, sperm or embryos to establish a pregnancy.[1]
  • ICSI is indicated for severe male factor (his severe oligoasthenoteratozoospermia): it bypasses the fertilisation barriers that conventional IVF cannot overcome, injecting a single spermatozoon into each mature oocyte — first reported by Palermo in 1992. ICSI is not a blanket upgrade over IVF.[2]

(b) The staged IVF/ICSI pathway (4 marks)

One mark per named pair of steps, maximum four. [3]

  • Pituitary suppression — prevent a premature LH surge (GnRH agonist or antagonist).[3]
  • Ovarian stimulation — gonadotrophins to recruit multiple follicles.[3]
  • Trigger — hCG or a GnRH agonist (in an antagonist cycle) to induce final oocyte maturation.
  • Oocyte retrieval — transvaginal ultrasound-guided pickup about 36 hours after the trigger.
  • Fertilisation — ICSI here (given severe male factor); conventional IVF otherwise.[2]
  • Embryo culture — to cleavage (day 3) or blastocyst (day 5).
  • Embryo transfer with luteal phase support — catheter transfer, then progesterone.[5]

(c) Protocol and embryo-transfer decisions with OHSS prevention (5 marks)

  • Protocol: use a GnRH antagonist protocol rather than the long agonist — Cochrane shows comparable live birth (OR 1.02) with a substantial reduction in OHSS (OR 0.61).[3]
  • Trigger: use a GnRH agonist trigger in place of hCG to reduce early OHSS, with modified luteal support or a freeze-all strategy.[3]
  • Luteal support: progesterone, never hCG — hCG carries a higher OHSS risk and should be avoided (Cochrane).[5]
  • Embryo transfer number: follow ASRM/SART guidance to promote singleton gestation — elective single embryo transfer given her good prognosis, transferring surplus embryos as frozen-thawed cycles.[6]
  • OHSS prevention ladder: individualise the gonadotrophin dose; antagonist protocol with agonist trigger; cabergoline if high response; metformin if PCOS; and a low threshold to freeze-all in high-risk cycles.[3][6]

(d) Counselling on success and complications (3 marks)

  • Cumulative live birth: quote Malizia — at 40 years or older, cumulative live birth after up to six cycles was 23% (conservative) to 42% (optimistic), versus 65% to 86% under 35. IVF may largely overcome infertility in younger women but does not reverse the age-dependent decline.[4]
  • Complications to name: OHSS (the iatrogenic emergency), multiple pregnancy (prevented by elective single embryo transfer), and the procedural risks of retrieval (bleeding, infection, torsion, anaesthetic).[6]
  • Perinatal risk: ART singletons carry slightly higher perinatal risk than non-ART singletons, but far less than ART multiple births, and much reflects the underlying subfertility rather than the technique itself.[6]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, Simpson JL, van der Poel S The International Glossary on Infertility and Fertility Care, 2017 Hum Reprod, 2017.PMID 29117321
  2. [2]Palermo G, Joris H, Devroey P, Van Steirteghem AC Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte Lancet, 1992.PMID 1351601
  3. [3]Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst Rev, 2016.PMID 27126581
  4. [4]Malizia BA, Hacker MR, Penzias AS Cumulative live-birth rates after in vitro fertilization N Engl J Med, 2009.PMID 19144939
  5. [5]van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M Luteal phase support for assisted reproduction cycles Cochrane Database Syst Rev, 2011.PMID 21975790
  6. [6]Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technologies Guidance on the limits to the number of embryos to transfer: a committee opinion Fertil Steril, 2021.PMID 34330423
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPlacental abruption — structured SAQ (15 marks)Antenatal care — obstetric haemorrhageNextOvarian hyperstimulation syndrome — structured SAQ (15 marks)Reproductive endocrinology and infertility